nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosutinib—Vandetanib—KDR—age related macular degeneration	0.00862	0.541	CrCbGaD
Bosutinib—Vandetanib—VEGFA—age related macular degeneration	0.00731	0.459	CrCbGaD
Bosutinib—SIK2—connective tissue—age related macular degeneration	0.00707	0.0206	CbGeAlD
Bosutinib—EPHB2—retina—age related macular degeneration	0.00676	0.0197	CbGeAlD
Bosutinib—EIF2AK1—eye—age related macular degeneration	0.00675	0.0196	CbGeAlD
Bosutinib—EIF2AK1—retina—age related macular degeneration	0.00669	0.0195	CbGeAlD
Bosutinib—EPHA8—eye—age related macular degeneration	0.00654	0.019	CbGeAlD
Bosutinib—SRMS—connective tissue—age related macular degeneration	0.00644	0.0187	CbGeAlD
Bosutinib—SYK—eye—age related macular degeneration	0.00642	0.0187	CbGeAlD
Bosutinib—SYK—connective tissue—age related macular degeneration	0.00618	0.018	CbGeAlD
Bosutinib—CDK2—connective tissue—age related macular degeneration	0.00613	0.0178	CbGeAlD
Bosutinib—DMPK—eye—age related macular degeneration	0.00603	0.0176	CbGeAlD
Bosutinib—DMPK—retina—age related macular degeneration	0.00598	0.0174	CbGeAlD
Bosutinib—STK25—eye—age related macular degeneration	0.00576	0.0168	CbGeAlD
Bosutinib—EPHA3—eye—age related macular degeneration	0.00572	0.0166	CbGeAlD
Bosutinib—EPHA3—retina—age related macular degeneration	0.00567	0.0165	CbGeAlD
Bosutinib—PLK2—connective tissue—age related macular degeneration	0.0054	0.0157	CbGeAlD
Bosutinib—CAMK1D—eye—age related macular degeneration	0.00529	0.0154	CbGeAlD
Bosutinib—CAMK1D—retina—age related macular degeneration	0.00525	0.0153	CbGeAlD
Bosutinib—STK24—eye—age related macular degeneration	0.00523	0.0152	CbGeAlD
Bosutinib—STK24—retina—age related macular degeneration	0.00518	0.0151	CbGeAlD
Bosutinib—STK4—connective tissue—age related macular degeneration	0.00516	0.015	CbGeAlD
Bosutinib—EPHA5—eye—age related macular degeneration	0.00506	0.0147	CbGeAlD
Bosutinib—EPHA5—retina—age related macular degeneration	0.00502	0.0146	CbGeAlD
Bosutinib—MAP4K1—retina—age related macular degeneration	0.00492	0.0143	CbGeAlD
Bosutinib—TYRO3—connective tissue—age related macular degeneration	0.00488	0.0142	CbGeAlD
Bosutinib—ALK—connective tissue—age related macular degeneration	0.00488	0.0142	CbGeAlD
Bosutinib—LYN—connective tissue—age related macular degeneration	0.00485	0.0141	CbGeAlD
Bosutinib—BTK—connective tissue—age related macular degeneration	0.00475	0.0138	CbGeAlD
Bosutinib—STK3—eye—age related macular degeneration	0.00473	0.0138	CbGeAlD
Bosutinib—ROCK1—eye—age related macular degeneration	0.00467	0.0136	CbGeAlD
Bosutinib—ROCK1—retina—age related macular degeneration	0.00463	0.0135	CbGeAlD
Bosutinib—ROCK1—connective tissue—age related macular degeneration	0.0045	0.0131	CbGeAlD
Bosutinib—MERTK—eye—age related macular degeneration	0.00445	0.0129	CbGeAlD
Bosutinib—MERTK—retina—age related macular degeneration	0.00441	0.0128	CbGeAlD
Bosutinib—BMPR2—connective tissue—age related macular degeneration	0.00437	0.0127	CbGeAlD
Bosutinib—BCR—eye—age related macular degeneration	0.00434	0.0126	CbGeAlD
Bosutinib—MAP3K12—eye—age related macular degeneration	0.0043	0.0125	CbGeAlD
Bosutinib—MAP2K1—eye—age related macular degeneration	0.00422	0.0123	CbGeAlD
Bosutinib—MAP4K4—connective tissue—age related macular degeneration	0.00421	0.0122	CbGeAlD
Bosutinib—CSK—eye—age related macular degeneration	0.00419	0.0122	CbGeAlD
Bosutinib—CSNK1A1—eye—age related macular degeneration	0.00416	0.0121	CbGeAlD
Bosutinib—CLK1—eye—age related macular degeneration	0.00414	0.012	CbGeAlD
Bosutinib—CLK1—retina—age related macular degeneration	0.0041	0.0119	CbGeAlD
Bosutinib—MAP2K1—connective tissue—age related macular degeneration	0.00406	0.0118	CbGeAlD
Bosutinib—CAMK2G—eye—age related macular degeneration	0.00406	0.0118	CbGeAlD
Bosutinib—CSK—connective tissue—age related macular degeneration	0.00404	0.0117	CbGeAlD
Bosutinib—CLK1—connective tissue—age related macular degeneration	0.00398	0.0116	CbGeAlD
Bosutinib—BMP2K—connective tissue—age related macular degeneration	0.00391	0.0114	CbGeAlD
Bosutinib—CSNK1E—retina—age related macular degeneration	0.00382	0.0111	CbGeAlD
Bosutinib—PTK2B—connective tissue—age related macular degeneration	0.00378	0.011	CbGeAlD
Bosutinib—ULK3—eye—age related macular degeneration	0.00371	0.0108	CbGeAlD
Bosutinib—ULK3—retina—age related macular degeneration	0.00368	0.0107	CbGeAlD
Bosutinib—SIK1—connective tissue—age related macular degeneration	0.00366	0.0106	CbGeAlD
Bosutinib—MAP3K7—retina—age related macular degeneration	0.00362	0.0105	CbGeAlD
Bosutinib—TBK1—eye—age related macular degeneration	0.00361	0.0105	CbGeAlD
Bosutinib—ERBB3—connective tissue—age related macular degeneration	0.00359	0.0104	CbGeAlD
Bosutinib—MAP3K2—connective tissue—age related macular degeneration	0.00355	0.0103	CbGeAlD
Bosutinib—PTK2—connective tissue—age related macular degeneration	0.00348	0.0101	CbGeAlD
Bosutinib—RPS6KB1—eye—age related macular degeneration	0.00347	0.0101	CbGeAlD
Bosutinib—RPS6KB1—retina—age related macular degeneration	0.00344	0.01	CbGeAlD
Bosutinib—AXL—eye—age related macular degeneration	0.00344	0.01	CbGeAlD
Bosutinib—AXL—retina—age related macular degeneration	0.00341	0.00991	CbGeAlD
Bosutinib—RPS6KB1—connective tissue—age related macular degeneration	0.00335	0.00973	CbGeAlD
Bosutinib—AXL—connective tissue—age related macular degeneration	0.00331	0.00964	CbGeAlD
Bosutinib—EPHB4—connective tissue—age related macular degeneration	0.00317	0.00921	CbGeAlD
Bosutinib—FYN—connective tissue—age related macular degeneration	0.0031	0.00902	CbGeAlD
Bosutinib—YES1—eye—age related macular degeneration	0.0029	0.00845	CbGeAlD
Bosutinib—YES1—retina—age related macular degeneration	0.00288	0.00837	CbGeAlD
Bosutinib—TAOK3—eye—age related macular degeneration	0.00287	0.00834	CbGeAlD
Bosutinib—TAOK3—retina—age related macular degeneration	0.00284	0.00827	CbGeAlD
Bosutinib—YES1—connective tissue—age related macular degeneration	0.0028	0.00814	CbGeAlD
Bosutinib—SRC—eye—age related macular degeneration	0.00279	0.00813	CbGeAlD
Bosutinib—SRC—retina—age related macular degeneration	0.00277	0.00805	CbGeAlD
Bosutinib—TAOK3—connective tissue—age related macular degeneration	0.00276	0.00804	CbGeAlD
Bosutinib—SRC—connective tissue—age related macular degeneration	0.00269	0.00783	CbGeAlD
Bosutinib—CSF1R—eye—age related macular degeneration	0.00251	0.0073	CbGeAlD
Bosutinib—CSF1R—connective tissue—age related macular degeneration	0.00242	0.00703	CbGeAlD
Bosutinib—PDGFRB—eye—age related macular degeneration	0.00222	0.00647	CbGeAlD
Bosutinib—PDGFRB—connective tissue—age related macular degeneration	0.00214	0.00623	CbGeAlD
Bosutinib—ABL1—eye—age related macular degeneration	0.00198	0.00577	CbGeAlD
Bosutinib—ABL1—retina—age related macular degeneration	0.00196	0.00572	CbGeAlD
Bosutinib—ABL1—connective tissue—age related macular degeneration	0.00191	0.00556	CbGeAlD
Bosutinib—ABCB1—retina—age related macular degeneration	0.000611	0.00178	CbGeAlD
Bosutinib—ERBB3—Immune System—TLR4—age related macular degeneration	4.31e-05	6.73e-05	CbGpPWpGaD
Bosutinib—EGFR—Innate Immune System—CRP—age related macular degeneration	4.3e-05	6.71e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—SQSTM1—age related macular degeneration	4.28e-05	6.69e-05	CbGpPWpGaD
Bosutinib—LYN—Axon guidance—VEGFA—age related macular degeneration	4.24e-05	6.62e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—SQSTM1—age related macular degeneration	4.22e-05	6.6e-05	CbGpPWpGaD
Bosutinib—EGFR—Disease—TGFBR1—age related macular degeneration	4.22e-05	6.59e-05	CbGpPWpGaD
Bosutinib—ABL1—Axon guidance—VEGFA—age related macular degeneration	4.22e-05	6.58e-05	CbGpPWpGaD
Bosutinib—PTK2—Immune System—C3—age related macular degeneration	4.21e-05	6.57e-05	CbGpPWpGaD
Bosutinib—LCK—Adaptive Immune System—C3—age related macular degeneration	4.18e-05	6.53e-05	CbGpPWpGaD
Bosutinib—SRC—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	4.17e-05	6.52e-05	CbGpPWpGaD
Bosutinib—FYN—Axon guidance—VEGFA—age related macular degeneration	4.17e-05	6.51e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—TGFBR1—age related macular degeneration	4.16e-05	6.5e-05	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—CD36—age related macular degeneration	4.15e-05	6.49e-05	CbGpPWpGaD
Bosutinib—YES1—Immune System—C3—age related macular degeneration	4.15e-05	6.48e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Axon guidance—VEGFA—age related macular degeneration	4.15e-05	6.48e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—SQSTM1—age related macular degeneration	4.14e-05	6.47e-05	CbGpPWpGaD
Bosutinib—LCK—Innate Immune System—CRP—age related macular degeneration	4.14e-05	6.47e-05	CbGpPWpGaD
Bosutinib—EGFR—Innate Immune System—TLR4—age related macular degeneration	4.12e-05	6.44e-05	CbGpPWpGaD
Bosutinib—PTK2—Developmental Biology—VEGFA—age related macular degeneration	4.11e-05	6.42e-05	CbGpPWpGaD
Bosutinib—SRC—Innate Immune System—CD36—age related macular degeneration	4.07e-05	6.35e-05	CbGpPWpGaD
Bosutinib—LCK—Disease—TGFBR1—age related macular degeneration	4.07e-05	6.35e-05	CbGpPWpGaD
Bosutinib—ERBB3—Disease—APOE—age related macular degeneration	4.06e-05	6.35e-05	CbGpPWpGaD
Bosutinib—YES1—Developmental Biology—VEGFA—age related macular degeneration	4.05e-05	6.33e-05	CbGpPWpGaD
Bosutinib—PTK2—Hemostasis—VEGFA—age related macular degeneration	4.03e-05	6.3e-05	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—C3—age related macular degeneration	4.01e-05	6.27e-05	CbGpPWpGaD
Bosutinib—SRC—Disease—CST3—age related macular degeneration	4.01e-05	6.26e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—SQSTM1—age related macular degeneration	4.01e-05	6.26e-05	CbGpPWpGaD
Bosutinib—PTK2—Immune System—CRP—age related macular degeneration	4e-05	6.25e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—SQSTM1—age related macular degeneration	3.99e-05	6.24e-05	CbGpPWpGaD
Bosutinib—SRC—Developmental Biology—KDR—age related macular degeneration	3.98e-05	6.22e-05	CbGpPWpGaD
Bosutinib—YES1—Hemostasis—VEGFA—age related macular degeneration	3.98e-05	6.21e-05	CbGpPWpGaD
Bosutinib—LCK—Innate Immune System—TLR4—age related macular degeneration	3.97e-05	6.2e-05	CbGpPWpGaD
Bosutinib—SYK—Signaling Pathways—CCL2—age related macular degeneration	3.96e-05	6.18e-05	CbGpPWpGaD
Bosutinib—YES1—Immune System—CRP—age related macular degeneration	3.95e-05	6.17e-05	CbGpPWpGaD
Bosutinib—FER—Signaling Pathways—VEGFA—age related macular degeneration	3.94e-05	6.16e-05	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—C3—age related macular degeneration	3.94e-05	6.15e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—CD36—age related macular degeneration	3.91e-05	6.11e-05	CbGpPWpGaD
Bosutinib—SRC—Adaptive Immune System—CD36—age related macular degeneration	3.91e-05	6.1e-05	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—CCL2—age related macular degeneration	3.89e-05	6.07e-05	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—CCL2—age related macular degeneration	3.89e-05	6.07e-05	CbGpPWpGaD
Bosutinib—SRC—Innate Immune System—C3—age related macular degeneration	3.86e-05	6.02e-05	CbGpPWpGaD
Bosutinib—ABCB1—Transmembrane transport of small molecules—CETP—age related macular degeneration	3.85e-05	6.01e-05	CbGpPWpGaD
Bosutinib—PTK2—Immune System—TLR4—age related macular degeneration	3.84e-05	5.99e-05	CbGpPWpGaD
Bosutinib—YES1—Immune System—TLR4—age related macular degeneration	3.79e-05	5.91e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—SQSTM1—age related macular degeneration	3.77e-05	5.89e-05	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—CCL2—age related macular degeneration	3.75e-05	5.86e-05	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—CRP—age related macular degeneration	3.74e-05	5.85e-05	CbGpPWpGaD
Bosutinib—AXL—Signaling Pathways—VEGFA—age related macular degeneration	3.74e-05	5.84e-05	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—APOE—age related macular degeneration	3.73e-05	5.83e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—C3—age related macular degeneration	3.71e-05	5.79e-05	CbGpPWpGaD
Bosutinib—SRC—Adaptive Immune System—C3—age related macular degeneration	3.7e-05	5.78e-05	CbGpPWpGaD
Bosutinib—SRC—Innate Immune System—CRP—age related macular degeneration	3.67e-05	5.73e-05	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—KDR—age related macular degeneration	3.66e-05	5.71e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—SLC16A8—age related macular degeneration	3.65e-05	5.7e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—TGFBR1—age related macular degeneration	3.64e-05	5.68e-05	CbGpPWpGaD
Bosutinib—EGFR—Axon guidance—VEGFA—age related macular degeneration	3.6e-05	5.63e-05	CbGpPWpGaD
Bosutinib—SRC—Disease—TGFBR1—age related macular degeneration	3.6e-05	5.62e-05	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—TLR4—age related macular degeneration	3.59e-05	5.61e-05	CbGpPWpGaD
Bosutinib—BMPR2—Signaling Pathways—VEGFA—age related macular degeneration	3.57e-05	5.57e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—TGFBR1—age related macular degeneration	3.55e-05	5.54e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling by GPCR—C3—age related macular degeneration	3.54e-05	5.54e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—SQSTM1—age related macular degeneration	3.53e-05	5.52e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—CRP—age related macular degeneration	3.53e-05	5.51e-05	CbGpPWpGaD
Bosutinib—SRC—Innate Immune System—TLR4—age related macular degeneration	3.52e-05	5.49e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—TGFBR1—age related macular degeneration	3.47e-05	5.42e-05	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—C3—age related macular degeneration	3.47e-05	5.41e-05	CbGpPWpGaD
Bosutinib—BCR—Signaling Pathways—VEGFA—age related macular degeneration	3.42e-05	5.34e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—TGFBR1—age related macular degeneration	3.42e-05	5.34e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—CD36—age related macular degeneration	3.42e-05	5.34e-05	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—C3—age related macular degeneration	3.42e-05	5.34e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—TGFBR1—age related macular degeneration	3.4e-05	5.31e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—TLR4—age related macular degeneration	3.38e-05	5.28e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—CD36—age related macular degeneration	3.34e-05	5.21e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by GPCR—C3—age related macular degeneration	3.32e-05	5.18e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—SQSTM1—age related macular degeneration	3.3e-05	5.15e-05	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—C3—age related macular degeneration	3.29e-05	5.14e-05	CbGpPWpGaD
Bosutinib—LYN—Immune System—CD36—age related macular degeneration	3.27e-05	5.1e-05	CbGpPWpGaD
Bosutinib—ABL1—Immune System—CD36—age related macular degeneration	3.25e-05	5.08e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—C3—age related macular degeneration	3.24e-05	5.06e-05	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—APOE—age related macular degeneration	3.23e-05	5.04e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—SQSTM1—age related macular degeneration	3.22e-05	5.02e-05	CbGpPWpGaD
Bosutinib—FYN—Immune System—CD36—age related macular degeneration	3.22e-05	5.02e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—CD36—age related macular degeneration	3.2e-05	4.99e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—NMNAT1—age related macular degeneration	3.19e-05	4.99e-05	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—APOE—age related macular degeneration	3.18e-05	4.97e-05	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—C3—age related macular degeneration	3.17e-05	4.95e-05	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—C3—age related macular degeneration	3.17e-05	4.95e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Developmental Biology—VEGFA—age related macular degeneration	3.16e-05	4.94e-05	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—KDR—age related macular degeneration	3.16e-05	4.94e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—C3—age related macular degeneration	3.16e-05	4.94e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—SQSTM1—age related macular degeneration	3.15e-05	4.92e-05	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—CCL2—age related macular degeneration	3.14e-05	4.9e-05	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—KDR—age related macular degeneration	3.12e-05	4.87e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—SQSTM1—age related macular degeneration	3.1e-05	4.84e-05	CbGpPWpGaD
Bosutinib—LYN—Immune System—C3—age related macular degeneration	3.09e-05	4.83e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—SQSTM1—age related macular degeneration	3.08e-05	4.82e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—CRP—age related macular degeneration	3.08e-05	4.81e-05	CbGpPWpGaD
Bosutinib—ABL1—Immune System—C3—age related macular degeneration	3.08e-05	4.81e-05	CbGpPWpGaD
Bosutinib—SRC—Axon guidance—VEGFA—age related macular degeneration	3.07e-05	4.8e-05	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—APOE—age related macular degeneration	3.06e-05	4.79e-05	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—C3—age related macular degeneration	3.06e-05	4.77e-05	CbGpPWpGaD
Bosutinib—FYN—Immune System—C3—age related macular degeneration	3.05e-05	4.76e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—C3—age related macular degeneration	3.03e-05	4.73e-05	CbGpPWpGaD
Bosutinib—LYN—Developmental Biology—VEGFA—age related macular degeneration	3.02e-05	4.72e-05	CbGpPWpGaD
Bosutinib—ABL1—Developmental Biology—VEGFA—age related macular degeneration	3.01e-05	4.7e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—CRP—age related macular degeneration	3.01e-05	4.7e-05	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—KDR—age related macular degeneration	3e-05	4.69e-05	CbGpPWpGaD
Bosutinib—FES—Signaling Pathways—VEGFA—age related macular degeneration	2.99e-05	4.67e-05	CbGpPWpGaD
Bosutinib—FYN—Developmental Biology—VEGFA—age related macular degeneration	2.98e-05	4.65e-05	CbGpPWpGaD
Bosutinib—LYN—Hemostasis—VEGFA—age related macular degeneration	2.97e-05	4.63e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Developmental Biology—VEGFA—age related macular degeneration	2.96e-05	4.62e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—TGFBR1—age related macular degeneration	2.95e-05	4.61e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—TLR4—age related macular degeneration	2.95e-05	4.61e-05	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—APOE—age related macular degeneration	2.95e-05	4.61e-05	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—APOE—age related macular degeneration	2.95e-05	4.61e-05	CbGpPWpGaD
Bosutinib—ABL1—Hemostasis—VEGFA—age related macular degeneration	2.95e-05	4.61e-05	CbGpPWpGaD
Bosutinib—LYN—Immune System—CRP—age related macular degeneration	2.94e-05	4.6e-05	CbGpPWpGaD
Bosutinib—ABL1—Immune System—CRP—age related macular degeneration	2.93e-05	4.58e-05	CbGpPWpGaD
Bosutinib—FYN—Hemostasis—VEGFA—age related macular degeneration	2.92e-05	4.56e-05	CbGpPWpGaD
Bosutinib—FYN—Immune System—CRP—age related macular degeneration	2.9e-05	4.53e-05	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—KDR—age related macular degeneration	2.89e-05	4.52e-05	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—KDR—age related macular degeneration	2.89e-05	4.52e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—CRP—age related macular degeneration	2.88e-05	4.5e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—TLR4—age related macular degeneration	2.88e-05	4.5e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—C3—age related macular degeneration	2.88e-05	4.5e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—TGFBR1—age related macular degeneration	2.85e-05	4.45e-05	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—APOE—age related macular degeneration	2.85e-05	4.44e-05	CbGpPWpGaD
Bosutinib—LYN—Immune System—TLR4—age related macular degeneration	2.82e-05	4.41e-05	CbGpPWpGaD
Bosutinib—ABL1—Immune System—TLR4—age related macular degeneration	2.81e-05	4.39e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—ELOVL4—age related macular degeneration	2.79e-05	4.36e-05	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—KDR—age related macular degeneration	2.79e-05	4.35e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—APOE—age related macular degeneration	2.78e-05	4.35e-05	CbGpPWpGaD
Bosutinib—FYN—Immune System—TLR4—age related macular degeneration	2.78e-05	4.34e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—CD36—age related macular degeneration	2.78e-05	4.34e-05	CbGpPWpGaD
Bosutinib—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	2.78e-05	4.33e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling by GPCR—CCL2—age related macular degeneration	2.77e-05	4.33e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—TLR4—age related macular degeneration	2.76e-05	4.32e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—C3—age related macular degeneration	2.72e-05	4.25e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—APOE—age related macular degeneration	2.72e-05	4.24e-05	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—CCL2—age related macular degeneration	2.71e-05	4.24e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—C3—age related macular degeneration	2.68e-05	4.19e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—SQSTM1—age related macular degeneration	2.68e-05	4.18e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—CD36—age related macular degeneration	2.68e-05	4.18e-05	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—CCL2—age related macular degeneration	2.67e-05	4.18e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—C3—age related macular degeneration	2.63e-05	4.11e-05	CbGpPWpGaD
Bosutinib—FYN—Disease—APOE—age related macular degeneration	2.62e-05	4.09e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—APOE—age related macular degeneration	2.6e-05	4.07e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by GPCR—CCL2—age related macular degeneration	2.6e-05	4.05e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—SQSTM1—age related macular degeneration	2.58e-05	4.03e-05	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—CCL2—age related macular degeneration	2.58e-05	4.02e-05	CbGpPWpGaD
Bosutinib—EGFR—Developmental Biology—VEGFA—age related macular degeneration	2.57e-05	4.02e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—C3—age related macular degeneration	2.54e-05	3.97e-05	CbGpPWpGaD
Bosutinib—SYK—Signaling Pathways—VEGFA—age related macular degeneration	2.54e-05	3.97e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—C3—age related macular degeneration	2.54e-05	3.96e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—APOE—age related macular degeneration	2.53e-05	3.96e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—TGFBR1—age related macular degeneration	2.52e-05	3.94e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—CRP—age related macular degeneration	2.5e-05	3.91e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—APOE—age related macular degeneration	2.5e-05	3.9e-05	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—VEGFA—age related macular degeneration	2.5e-05	3.9e-05	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—VEGFA—age related macular degeneration	2.5e-05	3.9e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—KDR—age related macular degeneration	2.48e-05	3.88e-05	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—CCL2—age related macular degeneration	2.48e-05	3.88e-05	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—CCL2—age related macular degeneration	2.48e-05	3.88e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—KDR—age related macular degeneration	2.45e-05	3.82e-05	CbGpPWpGaD
Bosutinib—LCK—Hemostasis—VEGFA—age related macular degeneration	2.43e-05	3.8e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—CRP—age related macular degeneration	2.41e-05	3.77e-05	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—VEGFA—age related macular degeneration	2.41e-05	3.76e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—TLR4—age related macular degeneration	2.4e-05	3.75e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—C3—age related macular degeneration	2.4e-05	3.74e-05	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—CCL2—age related macular degeneration	2.39e-05	3.74e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—CD36—age related macular degeneration	2.37e-05	3.7e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—APOE—age related macular degeneration	2.37e-05	3.7e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—KDR—age related macular degeneration	2.32e-05	3.62e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—TLR4—age related macular degeneration	2.31e-05	3.61e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—SQSTM1—age related macular degeneration	2.29e-05	3.57e-05	CbGpPWpGaD
Bosutinib—EGFR—Disease—APOE—age related macular degeneration	2.26e-05	3.53e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—CCL2—age related macular degeneration	2.25e-05	3.52e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—SLC16A8—age related macular degeneration	2.25e-05	3.51e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—C3—age related macular degeneration	2.25e-05	3.51e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—APOE—age related macular degeneration	2.23e-05	3.48e-05	CbGpPWpGaD
Bosutinib—SRC—Developmental Biology—VEGFA—age related macular degeneration	2.19e-05	3.43e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—KDR—age related macular degeneration	2.19e-05	3.41e-05	CbGpPWpGaD
Bosutinib—LCK—Disease—APOE—age related macular degeneration	2.18e-05	3.4e-05	CbGpPWpGaD
Bosutinib—SRC—Hemostasis—VEGFA—age related macular degeneration	2.15e-05	3.36e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—CRP—age related macular degeneration	2.14e-05	3.34e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—CCL2—age related macular degeneration	2.13e-05	3.32e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—CCL2—age related macular degeneration	2.1e-05	3.28e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—C3—age related macular degeneration	2.09e-05	3.27e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—TLR4—age related macular degeneration	2.05e-05	3.2e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—C3—age related macular degeneration	2.04e-05	3.19e-05	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—VEGFA—age related macular degeneration	2.02e-05	3.15e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—C3—age related macular degeneration	2e-05	3.12e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—CCL2—age related macular degeneration	1.99e-05	3.11e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—C3—age related macular degeneration	1.97e-05	3.08e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—C3—age related macular degeneration	1.96e-05	3.06e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—APOE—age related macular degeneration	1.95e-05	3.04e-05	CbGpPWpGaD
Bosutinib—SRC—Disease—APOE—age related macular degeneration	1.93e-05	3.01e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—KDR—age related macular degeneration	1.91e-05	2.98e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—APOE—age related macular degeneration	1.9e-05	2.97e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—CCL2—age related macular degeneration	1.88e-05	2.93e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—LIPC—age related macular degeneration	1.87e-05	2.92e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—KDR—age related macular degeneration	1.86e-05	2.91e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—APOE—age related macular degeneration	1.86e-05	2.91e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—APOE—age related macular degeneration	1.83e-05	2.86e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—KDR—age related macular degeneration	1.82e-05	2.85e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—APOE—age related macular degeneration	1.82e-05	2.85e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—CETP—age related macular degeneration	1.8e-05	2.82e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—KDR—age related macular degeneration	1.8e-05	2.81e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—KDR—age related macular degeneration	1.79e-05	2.79e-05	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—VEGFA—age related macular degeneration	1.74e-05	2.72e-05	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—VEGFA—age related macular degeneration	1.72e-05	2.68e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—C3—age related macular degeneration	1.7e-05	2.66e-05	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—VEGFA—age related macular degeneration	1.65e-05	2.58e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—C3—age related macular degeneration	1.64e-05	2.56e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—CCL2—age related macular degeneration	1.64e-05	2.56e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—CCL2—age related macular degeneration	1.6e-05	2.5e-05	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—VEGFA—age related macular degeneration	1.59e-05	2.49e-05	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—VEGFA—age related macular degeneration	1.59e-05	2.49e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—APOE—age related macular degeneration	1.58e-05	2.47e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—CCL2—age related macular degeneration	1.57e-05	2.44e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—KDR—age related macular degeneration	1.55e-05	2.42e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—CCL2—age related macular degeneration	1.54e-05	2.41e-05	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—VEGFA—age related macular degeneration	1.54e-05	2.4e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—CCL2—age related macular degeneration	1.53e-05	2.39e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—APOE—age related macular degeneration	1.53e-05	2.38e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—KDR—age related macular degeneration	1.5e-05	2.34e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—C3—age related macular degeneration	1.45e-05	2.27e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—VEGFA—age related macular degeneration	1.37e-05	2.13e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—APOE—age related macular degeneration	1.35e-05	2.11e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—VEGFA—age related macular degeneration	1.35e-05	2.11e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—CCL2—age related macular degeneration	1.33e-05	2.08e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—KDR—age related macular degeneration	1.32e-05	2.07e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—CCL2—age related macular degeneration	1.28e-05	2e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—VEGFA—age related macular degeneration	1.28e-05	2e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—VEGFA—age related macular degeneration	1.2e-05	1.88e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—LIPC—age related macular degeneration	1.15e-05	1.8e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CCL2—age related macular degeneration	1.14e-05	1.77e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CETP—age related macular degeneration	1.11e-05	1.74e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—CD36—age related macular degeneration	1.08e-05	1.69e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—VEGFA—age related macular degeneration	1.05e-05	1.64e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—VEGFA—age related macular degeneration	1.03e-05	1.6e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—VEGFA—age related macular degeneration	1.01e-05	1.57e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—VEGFA—age related macular degeneration	9.9e-06	1.55e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—VEGFA—age related macular degeneration	9.84e-06	1.54e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—APOE—age related macular degeneration	9.56e-06	1.49e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—VEGFA—age related macular degeneration	8.55e-06	1.34e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—VEGFA—age related macular degeneration	8.24e-06	1.29e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—VEGFA—age related macular degeneration	7.29e-06	1.14e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CD36—age related macular degeneration	6.68e-06	1.04e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—APOE—age related macular degeneration	5.89e-06	9.2e-06	CbGpPWpGaD
